CG
SNIPR BIOME Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SNIPR001 | Prevention of E. coli bloodstream infections in hematological cancer patients | Phase 2 |
| CF Phage Therapy | Clearance of Pseudomonas aeruginosa infections in Cystic Fibrosis | Discovery/Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| SNIPR001 | Prevention of E. coli bloodstream infections in hematological cancer patients | Phase 2 |
| CF Phage Therapy | Clearance of Pseudomonas aeruginosa infections in Cystic Fibrosis | Discovery/Preclinical |